Summary: A large new analysis reveals a clear biological association between traumatic brain injury (TBI) and higher long-term brain cancer mortality. Researchers examined nearly four decades of data from the TBI Model Systems National Database, following more than 20,000 civilian patients who received inpatient neurorehabilitation. After adjusting for age, sex, race, calendar year and known cancer risk factors, the team found that people with a history of TBI were 1.75 times more likely to die from brain cancer than the demographically matched general population.
Key Facts
- From incidence to survival: Unlike prior fragmented reports that suggested a link between head trauma and tumor development, this study is among the first to demonstrate that TBI is associated with worse survival outcomes—specifically increased brain cancer mortality—at the population level.
- Large, long-term database: Investigators analyzed the TBI Model Systems National Database covering 1987–2024, assembling a longitudinal cohort of over 20,000 civilian patients treated at 20 specialized inpatient rehabilitation centers.
- Striking risk by injury mechanism: Subgroup analysis showed an especially large increase in risk for those whose TBIs were caused by gunshot wounds: more than a 14-fold elevation in brain cancer mortality compared with matched controls.
- Mild but complicated TBI matters: Patients classified as having “mild but complicated” TBI—head injuries with intracranial abnormalities on imaging—experienced nearly a fourfold rise in brain cancer mortality.
- Biological explanation: Researchers point to chronic post-traumatic neuroinflammation and metabolic disturbance as plausible mechanisms. Persistent inflammatory signaling and an altered cellular environment after injury could promote malignant transformation over time.
- Clinical implications: The findings support a shift away from viewing TBI purely as an acute surgical event toward treating it as a chronic condition that may carry progressive neurological and oncological consequences, warranting long-term surveillance for selected survivors.
- Ongoing research: The HealthSpan Lab led by Dr. Daniel Daneshvar is expanding investigations to predict other long-term outcomes after TBI, including neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), and to identify modifiable factors that influence healthspan after injury.
Source: Mass General
Overview of the study: Mass General Brigham researchers led by Daniel Daneshvar, MD, PhD, and Charlotte Luster analyzed records from the TBI Model Systems National Database to determine whether people with a history of traumatic brain injury face higher brain cancer mortality than the general population. The resulting paper, published in Neuroepidemiology, is titled “Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study.”
Why this study matters
TBI affects millions worldwide, but its long-term biological consequences remain underappreciated. Determining whether TBI increases not just tumor incidence but the risk of dying from brain cancer is essential for informing follow-up care, counseling survivors and families, and identifying those who might benefit from targeted monitoring or preventive strategies.
Study questions and methods
The researchers asked whether people with TBI have higher brain cancer mortality than the general population and whether injury severity, mechanism, or behavioral risk factors modify that risk. They conducted a retrospective cohort study using the TBI Model Systems National Database, including 20,211 individuals admitted for inpatient rehabilitation between 1987 and 2024. Brain cancer deaths were identified through death certificate data. Observed deaths in the TBI cohort were compared to expected deaths in an age-, sex-, race- and calendar-year matched general population, with subgroup analyses by injury severity, mechanism and risk factors such as smoking and alcohol use.
Key results
Among 4,297 decedents in the cohort, 18 died from brain cancer. Overall, people with TBI had a standardized mortality ratio (SMR) of 1.75 (95% CI: 1.04–2.77) for brain cancer death compared to the matched general population. By subgroup, SMRs were especially elevated for gunshot wound–related TBI (SMR = 14.29, 95% CI: 2.95–41.75) and for mild but complicated TBI (SMR = 3.88, 95% CI: 1.06–9.94). Moderate-to-severe TBI showed an elevated but not statistically significant SMR of 1.52 (95% CI: 0.83–2.54), likely influenced by smaller subgroup sample sizes.
Clinical and public health implications
The findings suggest selected groups of TBI survivors—particularly those with penetrating injuries like gunshot wounds or with imaging-evident intracranial abnormalities—may warrant longer-term neurological surveillance. For clinicians, the results reinforce treating TBI as a chronic condition with potential late effects rather than only an acute event. For patients and caregivers, the study emphasizes the importance of ongoing follow-up and open discussion with care teams about long-term risks and symptom monitoring.
Next steps and future research
The research team plans to extend these analyses to study other catastrophic long-term outcomes, including neurodegenerative diseases such as ALS, and to explore how biological, behavioral and environmental factors interact to influence resilience or vulnerability after TBI. Future work aims to identify markers for early intervention and practical strategies to preserve function and improve healthspan after brain injury.
Authorship: In addition to Daniel Daneshvar and Charlotte Luster, authors include Shanti Pinto, Mitra McLarney, Evan D. Feigel, Saef Izzy, Brian Nahed and Joseph Giacino.
Paper cited: Luster C.B., et al. “Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study.” Neuroepidemiology. DOI: 10.1159/000552405
Funding: Supported by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): 90DPTB0027, 90DPTB0022 and 90DPTB0023.
Disclosures: Luster reports clinical funding from the Brain and Body Program funded by the NFLPA, outside the submitted work. Daneshvar reported personal fees for expert testimony, advisory roles and research funding from several programs outside the submitted work; a full list of disclosures is available in the paper.
Key Questions Answered:
Q: If I had a concussion or head injury, will I get brain cancer?
A: No. An increased relative risk does not mean brain cancer is guaranteed or common. The study found a 1.75-fold increase in brain cancer mortality across the cohort, but brain cancer remains a rare outcome. The absolute risk for any single survivor is still low.
Q: How could an injury cause a tumor years later?
A: Researchers hypothesize that severe or penetrating injuries can trigger a prolonged inflammatory response. When that inflammatory state persists, it may create a biological environment that increases the likelihood of cellular changes and tumor development over time.
Q: Should TBI survivors change their medical care?
A: Survivors—especially those with penetrating injuries or complicated imaging findings—should discuss long-term neurological follow-up with their providers. This study supports treating TBI as a chronic condition and considering extended monitoring based on individual risk factors.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by staff.
About this TBI and brain cancer research news
Author: Tim Sullivan
Source: Mass General Brigham
Contact: Tim Sullivan – Mass General Brigham
Image: Image credited to Neuroscience News
Abstract
Title: Brain Cancer Mortality following Traumatic Brain Injury (TBI): A TBI Model Systems Study
Introduction: Emerging evidence suggests TBI may increase risk for later brain cancer. This study compared brain cancer mortality among people with TBI to the general population.
Methods: Retrospective cohort of 20,211 individuals with TBI enrolled in the TBI Model Systems National Database (1987–2024). Brain cancer deaths were identified from death certificates. Standardized mortality ratios (SMRs) were calculated against an age-, sex-, race- and calendar-year matched general population.
Results: Among 4,297 decedents, 18 died of brain cancer. Overall SMR was 1.75 (95% CI: 1.04–2.77). Elevated brain cancer mortality was observed for gunshot wound–related TBI (SMR = 14.29; 95% CI: 2.95–41.75) and mild complicated TBI (SMR = 3.88; 95% CI: 1.06–9.94), but not significantly for moderate-to-severe TBI (SMR = 1.52; 95% CI: 0.83–2.54).
Conclusion: People who sustained a TBI had a 1.75-fold higher likelihood of dying from brain cancer than the general population, with particularly high risk following gunshot wound and mild complicated injuries. These results highlight priorities for prevention, long-term monitoring and further study of the mechanisms linking TBI to brain cancer mortality.